CAW
PGNX

Cornerstone Advisors (Washington)’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-239
Closed -$1K – 826
2020
Q1 		$1K Hold
239
– – ﹤0.01% 754
2019
Q4 		$1K Hold
239
– – ﹤0.01% 753
2019
Q3 		$1K Hold
239
– – ﹤0.01% 744
2019
Q2 		$1K Buy
+239
New +$1K ﹤0.01% 1472